Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
(2025, February 24)
Phase 3 Trials The large Phase 3 obesity trial (NCT06066515) is evaluating efficacy and safety versus placebo over ~76 weeks in adults with overweight or obesity without diabetes, targeting primary endpoints around weight reduction and metabolic outcomes
The impact of increased energy expenditure on cardiac function and energetics requires further investigation
These spheres are known as liposomes
Research into the area is far from complete
US$ 25.22
US$ 29.92
US$ 27.27
US$ 23.22
